CrushSCI.com
Journal Selection & Manuscript Polishing Services
MOLECULAR ASPECTS OF MEDICINE journal cover Medicine
Back to journal directory

Review Cycle Records

MOLECULAR ASPECTS OF MEDICINE

Elsevier SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 22025 JCR Q1
151.1Average days
142Median days
31Fastest days
334Longest days
652025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

118 days

Non-coding RNAs in pancreatitis: from mechanisms to therapeutics

AuthorsZengkan Du; Wenwen Shao; Chunqing Ou; Wangzheqi Zhang; Xiaoke Wang; Yuanchen Wang; Zhuan Liao; Wenbin Zou

AffiliationsDepartment of Gastroenterology, National Clinical Research Center for Digestive Diseases, Changhai Hospital, Naval Medical University, Shanghai, 200433, China; Shandong University of Traditional Chinese Medicine, Jinan, 250014, China; Naval Medical University, No.800, Xiangyin Road, Shanghai, 200433, China

Source PDF DOI Publisher page
94 days

Extracellular vesicles and their cargo molecules for peripheral nerve injuries and neuropathies: The composition, properties, and impact

AuthorsAnam Anjum; Abel Lindley; Meaghan Harley-Troxell; Xiaofeng Jia

AffiliationsDepartment of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, 21201, USA; Department of Orthopedics, University of Maryland School of Medicine, Baltimore, MD, 21201, USA; Department of Neurobiology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA; Fischell Department of Bioengineering, University of Maryland, College Park, MD, 20742, USA

Source PDF DOI Publisher page
334 days

Unravelling the mystery of hypoxia-induced miRNAs in breast cancer: A molecular cross-talk driving tumour progression and therapy resistance

AuthorsNamrta Sharma; Varsha Yadav; Saket Sinha; Laxmi Kumari; Anshika Sethi; Sapna Marcus; Mahendra Pratap Singh; Sharanjot Kaur; Nikhil Garg; Akhilesh Pathak; Balachandar Vellingir; Sanjay Kumar

AffiliationsDepartment of Biochemistry, All India Institute of Medical Sciences (AIIMS), India; Department of Experimental Medicine and Biotechnology, PGIMER, Chandigarh, India; Department of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), India; Department of General Surgery, All India Institute of Medical Sciences (AIIMS), India; Department of General Medicine, All India Institute of Medical Sciences (AIIMS), India; Department of Surgical Oncology, All India Institute of Medical Sciences (AIIMS), India; Department of Forensic Medicine and Toxicology, All India Institute of Medical Sciences (AIIMS), India; Department of Zoology, Central University of Punjab, India

Source PDF DOI Publisher page
83 days

Integrating immunopeptidomics with liquid biopsy for precision oncology

AuthorsDoryan Masmoudi; Catherine Alix-Panabières; Zahra Eslami-S

AffiliationsLaboratory of Rare Circulating Human Cells – University Medical Center of Montpellier, Montpellier, France; CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France; European Liquid Biopsy Society (ELBS), Hamburg, Germany

Source PDF DOI Publisher page
189 days

RNA editing of pathogenic variants causing inherited retinal diseases using endogenous ADAR-current and future perspectives

AuthorsManar Salameh; Nina Schneider; Johanna Valensi; Asodu Sandeep Sarma; Erez Y. Levanon; Shay Ben-Aroya; Dror Sharon

AffiliationsDepartment of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, 91120, Israel; The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel

Source PDF DOI Publisher page
62 days

Advancing precision medicine in pancreatic cancer using novel biomarkers and clinical targets

AuthorsDivya Murthy; Attila A. Seyhan; Petra den Hollander; Shaolei Lu; Nick A. Kuburich; Claire Gould; Andrew A. Karam; Katie Sun; Patrick G. Schupp; Howard Safran; Razelle Kurzrock; Wafik El-Deiry; Sendurai A. Mani

AffiliationsLegorreta Cancer Center, Warren Alpert Medical School, Brown University, Providence, RI, United States; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, United States; Joint Program in Cancer Biology, Brown University Health and Brown University, Providence, RI, United States; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI, United States; Hematology/Oncology Division, Department of Medicine, Brown University Health and Brown University, Providence, RI, United States; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin and the LaBahn Pancreatic Cancer Program, Milwaukee, WI, United States; Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI, United States

Source PDF DOI Publisher page
166 days

Glucagon-like peptide-1 receptor agonists across anti-inflammation

AuthorsDaohong Chen

AffiliationsResearch Institute, Changshan Biochemical Pharmaceutical, 71 Menglong Street, Zhengding New District, Shijiazhuang, Hebei, 050800, China

Source PDF DOI Publisher page
248 days

Dual-targeting strategies for cancer and diabetes: Converging pharmacological pathways and repurposed therapies

AuthorsGurjit Kaur Bhatti; Ishtiaq Ahmed; Abhishek Sehrawat; Pushpender Kumar Sharma; Ramesh Kandimalla; Kawaljit Singh Kaura; Jasvinder Singh Bhatti

AffiliationsDepartment of Medical Lab Technology, University Institute of Allied Health Sciences, Chandigarh University, Mohali, 140413, Punjab, India; University Centre for Research and Development, Chandigarh University, Mohali, 140413, Punjab, India; Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, 303002, India; Amity Center of Nanobiotechnology and Nanomedicine, Amity University Rajasthan, Jaipur, India; Department of Biochemistry, Kakatiya Medical College, Warangal, India; Department of Urology, All India Institute of Medical Sciences, Bathinda, Punjab, India

Source PDF DOI Publisher page
186 days

Metabolic dysregulation: Its role in diabetes mellitus and cancers

AuthorsShuang Dai; Jiacheng Li; Jing Xia; Yingtong Liu; Yan Li

AffiliationsHealth and Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, China; College of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China

Source PDF DOI Publisher page
31 days

Viral triggers and genetic predisposition in ocular autoimmunity: unraveling the breakdown of immune privilege and advancing targeted therapeutics

AuthorsJianhao Bai; Zhiyong Wu; Zhongqi Wan; Chun Zhao; Yin Liu; Tianyu Wang

AffiliationsDepartment of Ophthalmology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China; Shanghai Heping Eye Hospital, Shanghai, China; Department of Ophthalmology, Shanghai Tenth People's Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China; Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Ningbo Key Laboratory of Medical Research on Blinding Eye Diseases, Ningbo Eye Institute, Ningbo Eye Hospital, Wenzhou Medical University, Ningbo, 315040, China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.